QY Research, Inc.

Clinical Mass Spectrometry Market Will Expand at 5.40% CAGR to Hit 970 Million US$ by 2025: QY Research, Inc.

 

Los Angeles, CA -- (SBWIRE) -- 05/17/2019 -- Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics.

Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, Asia has little production, it only occupies about 10% market share in 2015. The largest company is Thermo Fisher, it occupies more than 26% of the market share, and the second largest company is AB Sciex (Danaher).

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1086113/global-clinical-mass-spectrometry-market

The largest consumption region is North America, it occupies about 46% market share in 2015, the second largest region is the Europe, it occupies about 32% market share, and the smallest consumption region is ROW, the consumption rate in China is about 6% in 2015.

In the last five years, the Clinical Mass Spectrometry has great consumption growth rate, it can be divided into two types LC-MS and GC-MS, the LC-MS occupies about 81% market share in 2015, in the application region, it mainly used in the Clinical Research, it occupies about 74% market share in 2015; In the future, the permeability will have high growth rate, the price have great relationship with the raw material and technology.

The global Clinical Mass Spectrometry market was 640 million US$ in 2018 and is expected to 970 million US$ by the end of 2025, growing at a CAGR of 5.4% between 2019 and 2025.

This report studies the Clinical Mass Spectrometry market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Clinical Mass Spectrometry in these regions, from 2014 to 2025, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Thermo Fisher

AB Sciex (Danaher)

Waters

Agilent

Bruker

Perkin Elmer

Shidmazu

By the product type, the market is primarily split into

LC-MS

GC-MS

By the end users/application, this report covers the following segments

Clinical Diagnostics

Clinical Research

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

Rest of Middle East & Africa

The study objectives of this report are:

To study and analyze the global Clinical Mass Spectrometry market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.

To understand the structure of Clinical Mass Spectrometry market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Clinical Mass Spectrometry manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Clinical Mass Spectrometry with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Clinical Mass Spectrometry submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Clinical Mass Spectrometry are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million USD) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Clinical Mass Spectrometry market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Get Full Report Now at USD 3,550 @ https://www.qyresearch.com/settlement/pre/0d6fb0165930dd9aa61283bef2097d0f,0,1,Global%20Clinical%20Mass%20Spectrometry%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.